Edited by Daniel K. Podolsky, Michael Camilleri, J.
Gregory Fitz,
Anthony
N. Kalloo, Fergus Shanahan, Timothy C. Wang
1. LevyAD, MurakataLA, AbbottRM, et al.From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic‐pathologic correlation. Armed Forces Institute of Pathology. Radiographics2002;22:387. CrossRef
2. KeechMK. Cystadenomata of the pancreas and intrahepatic bile ducts. Gastroenterology1951;19:568.
3. IshakKG, WillisGW, CumminsSD, et al.Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer1977;39:322. CrossRef
4. NeumannRD, LiVolsiVA, RosenthalNS, et al.Adenocarcinoma in biliary papillomatosis. Gastroenterology1976;70:779.
5. HelpapB. Malignant papillomatosis of the intrahepatic bile ducts. Acta Hepatogastroenterol (Stuttg)1977;24:419.
6. AssorD. Granular cell myoblastoma involving the common bile duct. Am J Surg1979;137:673. CrossRef
7. MansteinME, McBreartyFX, PellechiaPE, et al.Granular cell tumor of the common bile duct. Dig Dis Sci1981;26:938. CrossRef
8. ChristensenAH, IshakKG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol1970;90:423.
9. OotaniT, ShiraiY, TsukadaK, et al.Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer1992;69:2647. CrossRef
10. RosPR, GoodmanZD. Xanthogranulomatous cholecystitis versus gallbladder carcinoma. Radiology1997;203:10. CrossRef
11. PatelT. Cholangiocarcinoma–controversies and challenges. Nat Rev Gastroenterol Hepatol2011;8:189. CrossRef
12. RazumilavaN, GoresGJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol2013;11:13. CrossRef
13. DeOliveiraML, CunninghamSC, CameronJL, et al.Cholangiocarcinoma: thirty‐one‐year experience with 564 patients at a single institution. Ann Surg2007;245:755. CrossRef
14. ShinHR, OhJK, MasuyerE, et al.Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci2010;101:579. CrossRef
15. BroomeU, OlssonR, LoofL, et al.Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut1996;38:610. CrossRef
16. RitchieJK, AllanRN, MacartneyJ, et al.Biliary tract carcinoma associated with ulcerative colitis. Q J Med1974;43:263.
17. RossAP, BraaschJW. Ulcerative colitis and carcinoma of the proximal bile ducts. Gut1973;14:94. CrossRef
18. RazumilavaN, GoresGJ, LindorKD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology2011;54:1842. CrossRef
19. OnoJ, SakodaK, AkitaH. Surgical aspect ot cystic dilatation of the bile duct. An anomalous junction of the pancreaticobiliary tract in adults. Ann Surg1982;195:203. CrossRef
20. FlaniganDP. Biliary carcinoma associated with biliary cysts. Cancer1977;40:880. CrossRef
21. JanYY, ChenMF, WangCS, et al.Surgical treatment of hepatolithiasis: long‐term results. Surgery1996;120:509. CrossRef
22. BrandiG, Di GirolamoS, FarioliA, et al.Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case‐control analysis. Cancer Causes Control2013;24:91. CrossRef
23. KumagaiS, KurumataniN, ArimotoA, et al.Cholangiocarcinoma among offset colour proof‐printing workers exposed to 1,2‐dichloropropane and/or dichloromethane. Occup Environ Med2013;70:508. CrossRef
24. PalmerWC, PatelT. Are common factors involved in the pathogenesis of primary liver cancers? A meta‐analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol2012;57:69. CrossRef
25. BraconiC, PatelT. Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am2010;24:871. CrossRef
26. SiaD, TovarV, MoeiniA, et al.Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene2013;32:4861. CrossRef
27. SiaD, HoshidaY, VillanuevaA, et al.Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology2013;144:829. CrossRef
28. ShimadaH, NiimotoS, MatsubaA, et al.The infiltration of bile duct carcinoma along the bile duct wall. Int Surg1988;73:87.
29. PatelT. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology2001;33:1353. CrossRef
30. KhanSA, EmadossadatyS, LadepNG, et al.Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?J Hepatol2012;56:848. CrossRef
31. ShinHR, OhJK, MasuyerE, et al.Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma–focus on East and South‐Eastern Asia. Asian Pac J Cancer Prev2010;11:1159.
32. CapizziPJ, RosenCB, NagorneyDM. Intermittent jaundice by tumor emboli from intrahepatic cholangiocarcinoma. Gastroenterology1992;103:1669.
33. ChoiBI, HanJK, ShinYM, et al.Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging1995;20:357. CrossRef
34. SoyerP, BluemkeDA, HrubanRH, et al.Intrahepatic cholangiocarcinoma: findings on spiral CT during arterial portography. Eur J Radiol1994;19:37. CrossRef
35. SoyerP, BluemkeDA, SibertA, et al.MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging1995;20:126. CrossRef
36. GautierAL, VilgrainV, FlejouJF, et al.[Imaging of peripheral cholangiocarcinoma. Comparison with pathological anatomy]. Gastroenterol Clin Biol1996;20:139.
37. KhanSA, DavidsonBR, GoldinR, et al.Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut2002;51(Suppl 6):VI1. CrossRef
38. KhanSA, DavidsonBR, GoldinRD, et al.Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut2012;61:1657. CrossRef
39. ValleJ, WasanH, PalmerDH, et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med2010;362:1273. CrossRef
40. BlumgartLH, StainSC. Surgical treatment of cholangiocarcinoma. Cancer Treat Res1994;69:75. CrossRef
41. MasselliG, GualdiG. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging2008;33:444. CrossRef
42. LeeMG, ParkKB, ShinYM, et al.Preoperative evaluation of hilar cholangiocarcinoma with contrast‐enhanced three‐dimensional fast imaging with steady‐state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg2003;27:278. CrossRef
43. ChenYK, ParsiMA, BinmoellerKF, et al.Single‐operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc2011;74:805. CrossRef
44. FukudaY, TsuyuguchiT, SakaiY, et al.Diagnostic utility of peroral cholangioscopy for various bile‐duct lesions. Gastrointest Endosc2005;62:374. CrossRef
45. ShahRJ, LangerDA, AntillonMR, et al.Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol2006;4:219. CrossRef
46. ItoiT, OsanaiM, IgarashiY, et al.Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile duct lesions. Clin Gastroenterol Hepatol2010;8:934. CrossRef
47. MeiningA, ChenYK, PleskowD, et al.Direct visualization of indeterminate pancreaticobiliary strictures with probe‐based confocal laser endomicroscopy: a multicenter experience. Gastrointest Endosc2011;74:961. CrossRef
48. VerbeekPC, van LeeuwenDJ, de WitLT, et al.Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery1992;112:866.
49. JuntermannsB, KaiserGM, ReisH, et al.Klatskin‐mimicking lesions: still a diagnostical and therapeutical dilemma?Hepatogastroenterology2011;58:265.
50. WetterLA, RingEJ, PellegriniCA, et al.Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg1991;161:57. CrossRef
51. de BellisM, ShermanS, FogelEL, et al.Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc2002;56:720. CrossRef
52. De BellisM, ShermanS, FogelEL, et al.Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc2002;56:552. CrossRef
53. FogelEL, deBellisM, McHenryL, et al.Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc2006;63:71. CrossRef
54. FerrariAPJr, LichtensteinDR, SlivkaA, et al.Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc1994;40:140. CrossRef
55. PaulA, KaiserGM, MolmentiEP, et al.Klatskin tumors and the accuracy of the Bismuth‐Corlette classification. Am Surg2011;77:1695.
56. DeoliveiraML, SchulickRD, NimuraY, et al.New staging system and a registry for perihilar cholangiocarcinoma. Hepatology2011;53:1363. CrossRef
57. NeumaierCE, BertolottoM, PerroneR, et al.Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound1995;23:173. CrossRef
58. Darwish MuradS, KimWR, HarnoisDM, et al.Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology2012;143:88. CrossRef
59. Darwish MuradS, HeimbachJK, GoresGJ, et al.Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl2013;19:521. CrossRef
60. CalleryMP, StrasbergSM, DohertyGM, et al.Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J Am Coll Surg1997;185:33. CrossRef
61. BengmarkS, EkbergH, EvanderA, et al.Major liver resection for hilar cholangiocarcinoma. Ann Surg1988;207:120. CrossRef
62. WashburnWK, LewisWD, JenkinsRL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg1995;130:270. CrossRef
63. JarnaginWR, FongY, DeMatteoRP, et al.Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg2001;234:507. CrossRef
64. PinsonCW, RossiRL. Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg1988;12:52. CrossRef
65. IwasakiY, OkamuraT, OzakiA, et al.Surgical treatment for carcinoma at the confluence of the major hepatic ducts. Surg Gynecol Obstet1986;162:457.
66. SuCH, TsaySH, WuCC, et al.Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg1996;223:384. CrossRef
67. NagorneyDM, DonohueJH, FarnellMB, et al.Outcomes after curative resections of cholangiocarcinoma. Arch Surg1993;128:871. CrossRef
68. NakeebA, PittHA, SohnTA, et al.Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg1996;224:463. CrossRef
69. HochwaldSN, BurkeEC, JarnaginWR, et al.Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg1999;134:261. CrossRef
70. SakataJ, ShiraiY, WakaiT, et al.Catheter tract implantation metastases associated with percutaneous biliary drainage for extrahepatic cholangiocarcinoma. World J Gastroenterol2005;11:7024. CrossRef
71. FerreroA, Lo TesoriereR, ViganoL, et al.Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg2009;33:318. CrossRef
72. LiuF, LiY, WeiY, et al.Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci2011;56:663. CrossRef
73. HiiMW, GibsonRN, SpeerAG, et al.Role of radiology in the treatment of malignant hilar biliary strictures 2: 10 years of single‐institution experience with percutaneous treatment. Australas Radiol2003;47:393. CrossRef
74. WitzigmannH, LangH, LauerH. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford)2008;10:154. CrossRef
75. ZhangBH, ChengQB, LuoXJ, et al.Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases. Hepatobiliary Pancreat Dis Int2006;5:278.
76. OrtnerME, CacaK, BerrF, et al.Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology2003;125:1355. CrossRef
77. ZoepfT, JakobsR, ArnoldJC, et al.Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol2005;100:2426. CrossRef
78. CheonYK, ChoYD, BaekSH, et al.[Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage]. Korean J Gastroenterol2004;44:280.
79. YamaoK, HaraK, MizunoN, et al.EUS‐guided biliary drainage. Gut Liver2010;4(Suppl 1):S67. CrossRef
80. YamaoK, BhatiaV, MizunoN, et al.EUS‐guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long‐term follow‐up. Endoscopy2008;40:340. CrossRef
81. Park doH, KooJE, OhJ, et al.EUS‐guided biliary drainage with one‐step placement of a fully covered metal stent for malignant biliary obstruction: a prospective feasibility study. Am J Gastroenterol2009;104:2168. CrossRef
82. KahalehM, HernandezAJ, TokarJ, et al.EUS‐guided pancreaticogastrostomy: analysis of its efficacy to drain inaccessible pancreatic ducts. Gastrointest Endosc2007;65:224. CrossRef
83. MarankiJ, HernandezAJ, ArslanB, et al.Interventional endoscopic ultrasound‐guided cholangiography: long‐term experience of an emerging alternative to percutaneous transhepatic cholangiography. Endoscopy2009;41:532. CrossRef
84. SteelAW, PostgateAJ, KhorsandiS, et al.Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc2011;73:149. CrossRef
85. OhnishiH, AsadaM, ShichijoY, et al.External radiotherapy for biliary decompression of hilar cholangiocarcinoma. Hepatogastroenterology1995;42:265.
86. LeungJ, GuineyM, DasR. Intraluminal brachytherapy in bile duct carcinomas. Aust N Z J Surg1996;66:74. CrossRef
87. KuvshinoffBW, ArmstrongJG, FongY, et al.Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg1995;82:1522. CrossRef
88. PittHA, NakeebA, AbramsRA, et al.Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg1995;221:788. CrossRef
89. NicholsJC, GoresGJ, LaRussoNF, et al.Diagnostic role of serum CA 19‐9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc1993;68:874. CrossRef
90. RamageJK, DonaghyA, FarrantJM, et al.Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology1995;108:865. CrossRef
91. NakeebA, LipsettPA, LillemoeKD, et al.Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg1996;171:147. CrossRef
92. StamatakisJD, HowardER, WilliamsR. Benign inflammatory tumour of the common bile duct. Br J Surg1979;66:257. CrossRef
93. TioTL, ChengJ, WijersOB, et al.Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging. Gastroenterology1991;100:1351.
94. WarshawAL, TepperJE, ShipleyWU. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg1986;151:76. CrossRef
95. JohnTG, GreigJD, CrosbieJL, et al.Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg1994;220:711. CrossRef
96. KlugeR, SchmidtF, CacaK, et al.Positron emission tomography with [(18)F]fluoro‐2‐deoxy‐D‐glucose for diagnosis and staging of bile duct cancer. Hepatology2001;33:1029. CrossRef
97. McLeodRS, TaylorBR, O'ConnorBI, et al.Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg1995;169:179. CrossRef
98. StrasbergSM, DrebinJA, SoperNJ. Evolution and current status of the Whipple procedure: an update for gastroenterologists. Gastroenterology1997;113:983. CrossRef
99. SmithAC, DowsettJF, RussellRC, et al.Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet1994;344:1655. CrossRef
100. PiehlerJM, CrichlowRW. Primary carcinoma of the gallbladder. Surg Gynecol Obstet1978;147:929.
101. MaringhiniA, MoreauJA, MeltonLJ3rd, et al.Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med1987;107:30. CrossRef
102. StromBL, SolowayRD, Rios‐DalenzJ, et al.Biochemical epidemiology of gallbladder cancer. Hepatology1996;23:1402. CrossRef
103. DiehlAK. Gallstone size and the risk of gallbladder cancer. JAMA1983;250:2323. CrossRef
104. ChijiiwaK, KimuraH, TanakaM. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg1995;80:61.
105. TodaniT, TokiA. [Cancer arising in choledochal cyst and management]. Nihon Geka Gakkai Zasshi1996;97:594.
106. TokiwaK, IwaiN. Early mucosal changes of the gallbladder in patients with anomalous arrangement of the pancreaticobiliary duct. Gastroenterology1996;110:1614. CrossRef
107. StephenAE, BergerDL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery2001;129:699. CrossRef
108. TowfighS, McFaddenDW, CortinaGR, et al.Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg2001;67:7.
109. StromBL, SolowayRD, Rios‐DalenzJL, et al.Risk factors for gallbladder cancer. An international collaborative case‐control study. Cancer1995;76:1747. CrossRef
110. NeugutAI, WylieP, Brandt‐RaufPW. Occupational cancers of the gastrointestinal tract. II. Pancreas, liver, and biliary tract. Occup Med1987;2:137.
111. ManoH, RoaI, ArayaJC, et al.Comparison of mutagenic activity of bile between Chilean and Japanese female patients having cholelithiasis. Mutat Res1996;371:73. CrossRef
112. DiehlAK, BeralV. Cholecystectomy and changing mortality from gallbladder cancer. Lancet1981;2:187. CrossRef
113. Albores‐SaavedraJ, HensonDE. Atlas of Tumor Pathology, 2nd Series, Fascicle 22: Tumors of the Gallbladder and Extrahepatic Bile Ducts. Washington DC: Armed Forces Institute of Pathology; 1986.
114. RoaI, ArayaJC, VillasecaM, et al.Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology1996;111:232. CrossRef
115. HanadaK, ItohM, FujiiK, et al.K‐ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer1996;77:452. CrossRef
116. KanekoK, AndoH, UmedaT, et al.A new model for pancreaticobiliary maljunction without bile duct dilatation: demonstration of cell proliferation in the gallbladder epithelium. J Surg Res1996;60:115. CrossRef
117. WistubaII, GazdarAF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer2004;4:695. CrossRef
118. WibbenmeyerLA, WadeTP, ChenRC, et al.Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder. J Am Coll Surg1995;181:504.
119. OhtaniT, ShiraiY, TsukadaK, et al.Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging1996;21:195. CrossRef
120. NevinJE, MoranTJ, KayS, et al.Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer1976;37:141. CrossRef
121. TsukadaK, HatakeyamaK, KurosakiI, et al.Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery1996;120:816. CrossRef
122. JohnstonePA, RohdeDC, SwartzSE, et al.Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy. J Clin Oncol1996;14:1950.
123. CopherJC, RogersJJ, DaltonML. Trocar‐site metastasis following laparoscopic cholecystectomy for unsuspected carcinoma of the gallbladder. Case report and review of the literature. Surg Endosc1995;9:348. CrossRef
124. DoudleM, KingG, ThomasWM, et al.The movement of mucosal cells of the gallbladder within the peritoneal cavity during laparoscopic cholecystectomy. Surg Endosc1996;10:1092. CrossRef
125. TodaK, SoudaS, YoshikawaY, et al.Significance of laparoscopic excisional biopsy for polypoid lesions of the gallbladder. Surg Laparosc Endosc1995;5:267. CrossRef
126. KubotaK, BandaiY, NoieT, et al.How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy?Surgery1995;117:481. CrossRef
127. AkosaAB, BarkerF, DesaL, et al.Cytologic diagnosis in the management of gallbladder carcinoma. Acta Cytol1995;39:494.
128. WuSS, LinKC, SoonMS, et al.Ultrasound‐guided percutaneous transhepatic fine needle aspiration cytology study of gallbladder polypoid lesions. Am J Gastroenterol1996;91:1591.
129. ChaoTC, WangCS, JengLB, et al.Primary carcinoma of the gallbladder in Taiwan. J Surg Oncol1996;61:49. CrossRef
130. RuckertJC, RuckertRI, GellertK, et al.Surgery for carcinoma of the gallbladder. Hepatogastroenterology1996;43:527.
131. OnoyamaH, YamamotoM, TsengA, et al.Extended cholecystectomy for carcinoma of the gallbladder. World J Surg1995;19:758. CrossRef
132. MiyazakiM, ItohH, AmbiruS, et al.Radical surgery for advanced gallbladder carcinoma. Br J Surg1996;83:478. CrossRef
133. HatfieldAR, TobiasR, TerblancheJ, et al.Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet1982;2:896. CrossRef
134. McPhersonGA, BenjaminIS, HodgsonHJ, et al.Pre‐operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg1984;71:371. CrossRef
135. PittHA, GomesAS, LoisJF, et al.Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?Ann Surg1985;201:545. CrossRef
136. PhilipPA, MahoneyMR, AllmerC, et al.Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol2006;24:3069. CrossRef
137. LubnerSJ, MahoneyMR, KolesarJL, et al.Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. J Clin Oncol2010;28:3491. CrossRef
138. UnoT, ItamiJ, ArugaM, et al.Primary carcinoma of the gallbladder: role of external beam radiation therapy in patients with locally advanced tumor. Strahlenther Onkol1996;172:496.
139. TodorokiT, IwasakiY, OriiK, et al.Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg1991;15:357. CrossRef
140. EckelF, BrunnerT, JelicS, et al.Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol2011;22:vi40. CrossRef
141. UesakaK, YasuiK, MorimotoT, et al.Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension. J Am Coll Surg1996;183:345.
142. GlennF, HaysDM. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet1954;99:529.
143. NerviF, DuarteI, GomezG, et al.Frequency of gallbladder cancer in Chile, a high‐risk area. Int J Cancer1988;41:657. CrossRef
144. StromBL, NelsonWL, HensonDE, et al.Carcinoma of the gallbladder. In: CohenS, SolowayRD(eds). Gallstones. New York: Churchill Livingstone; 1985: 275.